Industry veteran Martin Leeks has been appointed as the head of international medical malpractice, signalling the company’s ambitious entry into the healthcare underwriting market.
The new division will focus on delegated portfolios across key markets, including Australia, Canada, the UK, and Europe, underwriting on Lloyd’s paper. Known for its expertise in delegated authority portfolios and innovative underwriting solutions, Carbon aims to bring fresh energy and insight to the healthcare sector.
Leeks joins Carbon with over 35 years of experience in international casualty and medical malpractice underwriting. His previous role at Everest Group saw him develop profitable portfolios, a track record he is now set to replicate at Carbon.
Nicholas Tye, founder and CEO of Carbon, emphasised the significance of this appointment “Martin’s appointment is a fantastic step forward for Carbon as we launch our international healthcare division. This is more than just a strategic expansion – it’s a statement of our intent to bring fresh energy, innovation, and insight to the healthcare market. With the support of both Carbon’s analytics and our collaborative culture, I have no doubt Martin will support our growth into healthcare with distinction. His ambition, expertise, and vision are just what we need to establish Carbon as a leader in international healthcare underwriting. Welcome aboard, Martin, I am excited to see what we achieve together.”
The launch of the healthcare division follows the recent appointment of Alex Poracchia as Carbon’s chief financial officer, further bolstering the company’s leadership team.
Speaking about his new role, Leeks expressed enthusiasm for the opportunities ahead “The international healthcare market is ripe with opportunity, and I couldn’t be more thrilled to join the fast-growing Carbon team. This is a company with a great reputation, that doesn’t just talk about innovation, it lives and breathes it, from its people to its technology. With unparalleled data insights and a culture that fosters creativity and support, I’m confident we’ll deliver a market-leading portfolio.”
Carbon’s move into international healthcare highlights its ongoing commitment to innovation and growth. With Leeks at the helm of this new division, the company is poised to establish itself as a key player in the global healthcare underwriting landscape.
